Flynn has an average return of 20.8% when recommending Amgen Inc.
According to TipRanks.com, Flynn is ranked #586 out of 5142 analysts.
Currently, the analyst consensus on Amgen Inc is a Moderate Buy with an average price target of $207.33, implying a 4.8% upside from current levels. In a report issued on December 2, Oppenheimer also assigned a Buy rating to the stock with a $224 price target.
The company has a one-year high of $210.19 and a one-year low of $163.31. Currently, Amgen Inc has an average volume of 2.82M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.